Drugs / fibroblasts
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01874015 Comparator | Feb 2013 → Dec 2017 | Crohn disease | Royan Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fibroblasts | “group B receives autologous MSCs+ Fibroblasts” NCT01874015 ↗ |
| Modality | Cell therapy | “group B receives autologous MSCs+ Fibroblasts” NCT01874015 ↗ |